tiprankstipranks
Trending News
More News >
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market
Advertisement

Marvel Biosciences Corp (MRVL) Income Statement

Compare
29 Followers

Marvel Biosciences Corp Income Statement

Last quarter (Q3 2025), Marvel Biosciences Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Marvel Biosciences Corp's net income was C$-257.41K. See Marvel Biosciences Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ -887.52KC$ -1.38MC$ -613.10KC$ -265.20K
Operating Expenses
C$ 1.22KC$ 2.32MC$ 1.17MC$ 485.04KC$ 689.57K
Depreciation and Amortization
C$ 1.22KC$ 66.92KC$ 152.00C$ 185.00C$ 413.00
EBITDA
C$ -1.54MC$ -2.25MC$ -2.51MC$ -1.25MC$ -1.02M
Operating Income
C$ -1.22KC$ -2.32MC$ -2.54MC$ 806.33KC$ -954.20K
Other Income/Expenses
C$ -425.00C$ 27.54KC$ -5.86KC$ -1.79MC$ 63.36K
Pretax Income
C$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04MC$ -955.66K
Net Income
C$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04MC$ -955.66K
Per Share Metrics
Basic EPS
C$ -41.30C$ -0.06C$ -0.08C$ -0.09C$ -0.13
Diluted EPS
C$ -41.30C$ -0.06C$ -0.08C$ -0.09C$ -0.13
Weighted Average Shares Outstanding
39.96M 39.66M 32.76M 32.59M 7.37M
Weighted Average Shares Outstanding (Diluted)
39.96M 39.66M 32.76M 32.59M 7.37M
Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis